title: Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages.
authors.affiliation: Promedior, Inc, Malvern, Pennsylvania, United States of America. MurrayL@MedImmune.com
authors.forename: Lynne A
authors.initials: LA
authors.lastname: Murray
authors.forename: Rogerio
authors.initials: R
authors.lastname: Rosada
authors.forename: Ana Paula
authors.initials: AP
authors.lastname: Moreira
authors.forename: Amrita
authors.initials: A
authors.lastname: Joshi
authors.forename: Michael S
authors.initials: MS
authors.lastname: Kramer
authors.forename: David P
authors.initials: DP
authors.lastname: Hesson
authors.forename: Rochelle L
authors.initials: RL
authors.lastname: Argentieri
authors.forename: Susan
authors.initials: S
authors.lastname: Mathai
authors.forename: Mridu
authors.initials: M
authors.lastname: Gulati
authors.forename: Erica L
authors.initials: EL
authors.lastname: Herzog
authors.forename: Cory M
authors.initials: CM
authors.lastname: Hogaboam
mesh_terms: D000368:Aged; D000818:Animals; D001761:Bleomycin / Q000494:pharmacology*; D003094:Collagen / Q000378:metabolism; D005260:Female; D005355:Fibrosis; D006801:Humans; D008168:Lung / Q000473:pathology; D008171:Lung Diseases / Q000473:pathology; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051379:Mice; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000139:chemically induced*; D000683:Serum Amyloid P-Component / Q000096:biosynthesis*
chemical_list: D000683:Serum Amyloid P-Component; D001761:Bleomycin; D003094:Collagen